secwatch.observer — SEC 8-K summary
======================================

Issuer:     Comera Life Sciences Holdings, Inc. (—)
CIK:        0001907685
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0000950170-23-058855
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Comera receives Nasdaq delisting notice; expects to trade on OTC Markets
------------------------------------------------------------------------

- On Oct 31, 2023, Comera notified by Nasdaq of failure to cure $1.00 minimum bid price deficiency within 180-day period; not eligible for second period.
- Hearings panel to consider this deficiency; Company must submit written views by Nov 7, 2023.
- Previously, Nasdaq granted conditional continued listing until Nov 14, 2023, subject to meeting bid price and MVLS rules.
- Company believes it is unlikely to regain compliance by Nov 14; expects delisting and trading on OTC Markets.
- If delisted, Comera will remain an SEC reporting company under Exchange Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023058855/0000950170-23-058855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023058855/cmra-20231031.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-058855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer